Maher, Toby M <br/><br/>
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial.  [electronic resource] 

 -  BMJ open respiratory research  2018 
 - e000289 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2052-4439 
<br/><br/><label>Standard No.: </label>10.1136/bmjresp-2018-000289  doi